Venus Remedies Limited (NSE:VENUSREM) — Stock Price

Rs1522.60 INR
▼ -1.17% today

Venus Remedies Limited (NSE:VENUSREM) is currently trading at Rs1522.60 INR, down 1.17% today. Over the past 52 weeks, shares have ranged between Rs431.30 and Rs1947.00. This page tracks Venus Remedies Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Venus Remedies Limited stock valuation.

Venus Remedies Limited (VENUSREM) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Venus Remedies Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Venus Remedies Limited Income Statement — Revenue, Profit & Earnings by Year

Venus Remedies Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs6.48 Billion Rs5.91 Billion Rs5.56 Billion Rs5.99 Billion Rs5.48 Billion
Cost of Revenue Rs4.82 Billion Rs3.73 Billion Rs3.31 Billion Rs3.98 Billion Rs3.52 Billion
Gross Profit Rs1.66 Billion Rs2.18 Billion Rs2.25 Billion Rs2.00 Billion Rs1.96 Billion
Research & Development Rs180.80 Million Rs158.40 Million Rs228.90 Million Rs230.30 Million Rs118.70 Million
SG&A Rs1.76 Billion Rs127.69 Million Rs115.55 Million Rs91.08 Million Rs111.64 Million
Total Operating Expenses Rs1.25 Billion Rs1.85 Billion Rs1.63 Billion Rs1.72 Billion Rs1.78 Billion
Operating Income Rs410.30 Million Rs331.57 Million Rs273.20 Million Rs280.97 Million Rs315.14 Million
EBITDA Rs944.10 Million Rs711.80 Million Rs703.46 Million Rs701.40 Million Rs545.57 Million
EBIT Rs719.00 Million Rs447.37 Million Rs380.48 Million Rs366.06 Million Rs192.81 Million
Interest Expense Rs700.00K Rs937.00K Rs1.18 Million Rs4.81 Million Rs130.19 Million
Income Before Tax Rs718.30 Million Rs446.43 Million Rs379.30 Million Rs364.08 Million Rs485.53 Million
Income Tax Expense Rs265.10 Million Rs161.53 Million Rs113.60 Million Rs-43.16 Million Rs-132.12 Million
Net Income Rs453.20 Million Rs284.91 Million Rs265.70 Million Rs407.24 Million Rs617.65 Million

Venus Remedies Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Venus Remedies Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs7.16 Billion Rs6.27 Billion Rs6.01 Billion Rs5.80 Billion Rs5.56 Billion
Total Current Assets Rs4.52 Billion Rs3.60 Billion Rs3.23 Billion Rs2.78 Billion Rs2.32 Billion
Cash & Equivalents Rs575.20 Million Rs489.56 Million Rs212.10 Million Rs432.56 Million Rs288.79 Million
Short-term Investments Rs987.73 Million Rs348.49 Million Rs508.65 Million Rs20.55 Million Rs3.76 Million
Net Receivables Rs1.12 Billion Rs817.06 Million Rs778.09 Million Rs726.79 Million Rs660.33 Million
Inventory Rs1.00 Billion Rs1.22 Billion Rs1.20 Billion Rs1.26 Billion Rs1.20 Billion
Property, Plant & Equipment Rs1.51 Billion Rs1.54 Billion Rs1.63 Billion Rs1.78 Billion Rs1.90 Billion
Goodwill — Rs10.00K Rs-61.00K — —
Total Liabilities Rs1.55 Billion Rs1.39 Billion Rs1.41 Billion Rs1.39 Billion Rs1.56 Billion
Total Current Liabilities Rs1.36 Billion Rs794.16 Million Rs825.70 Million Rs927.38 Million Rs974.45 Million
Long-term Debt Rs0.00 Rs386.80 Million Rs386.80 Million Rs386.79 Million Rs468.31 Million
Net Debt Rs-784.10 Million Rs-76.30 Million Rs210.80 Million Rs-4.11 Million Rs224.39 Million
Total Stockholder Equity Rs5.61 Billion Rs4.88 Billion Rs4.60 Billion Rs4.40 Billion Rs4.00 Billion
Retained Earnings Rs2.15 Billion Rs1.70 Billion Rs1.42 Billion Rs1.16 Billion Rs750.57 Million

Venus Remedies Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Venus Remedies Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs909.20 Million Rs372.85 Million Rs366.20 Million Rs410.01 Million Rs1.33 Billion
Capital Expenditures Rs96.30 Million Rs93.18 Million Rs78.18 Million Rs137.08 Million Rs77.28 Million
Free Cash Flow Rs812.90 Million Rs278.40 Million Rs288.02 Million Rs272.94 Million Rs1.25 Billion
Investing Cash Flow Rs-807.90 Million Rs-72.09 Million Rs-508.30 Million Rs-166.26 Million Rs557.16 Million
Financing Cash Flow Rs-9.50 Million Rs-10.83 Million Rs-5.70 Million Rs-94.77 Million Rs-1.62 Billion
Dividends Paid — — — — —
Stock-Based Compensation — — — — —
Depreciation Rs225.10 Million Rs264.43 Million Rs323.00 Million Rs335.34 Million Rs352.76 Million
Change in Cash Rs277.71 Million Rs277.44 Million Rs-220.50 Million Rs143.76 Million Rs269.37 Million

Venus Remedies Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Venus Remedies Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Feb 10, 2026 — — —
Feb 12, 2025 — — —
Jun 30, 2014 8.96 14.38 -37.69%
May 30, 2014 12.33 13.60 -9.34%
Feb 12, 2014 15.06 13.74 +9.61%
Nov 22, 2013 13.11 14.20 -7.68%
Aug 05, 2013 13.38 11.96 +11.87%
Feb 07, 2013 16.48 12.68 +29.97%